Operaciones de insiders

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

• F1 Represents shares withheld by Zimmer Biomet Holdings, Inc. (the Company) to satisfy tax withholding obligations on the vesting of restricted stock units (RSUs).

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

• F1 Represents shares withheld by Zimmer Biomet Holdings, Inc. (the Company) to satisfy tax withholding obligations on the vesting of restricted stock units (RSUs).

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

• F2 Each RSU represents a contingent right to receive one share of Company common stock.

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

• F2 Each RSU represents a contingent right to receive one share of Company common stock.
• F3 One-third of these RSUs vested on October 1, 2026. The remaining RSUs vest one-half on October 1, 2027 and one-half on October 1, 2028.

Grant, award or other acquisition pursuant to Rule 16b-3(d)

• F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors
• F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
• F3 Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.
• F4 Includes 49.652 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Grant, award or other acquisition pursuant to Rule 16b-3(d)

• F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
• F3 Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
• F4 Includes 7.276 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Grant, award or other acquisition pursuant to Rule 16b-3(d)

• F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
• F3 Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.
• F4 Includes 96.739 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Grant, award or other acquisition pursuant to Rule 16b-3(d)

• F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
• F3 Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.
• F4 Includes 32.614 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Grant, award or other acquisition pursuant to Rule 16b-3(d)

• F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
• F3 Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
• F4 Includes 9.178 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Grant, award or other acquisition pursuant to Rule 16b-3(d)

• F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
• F3 Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
• F4 Includes 17.252 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Grant, award or other acquisition pursuant to Rule 16b-3(d)

• F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
• F3 Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.
• F4 Includes 85.331 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Open market or private sale of non-derivative or derivative security

Open market or private sale of non-derivative or derivative security

• F1 Includes 471 shares acquired under the Employee Stock Purchase Plan and pursuant to dividend reinvestment through July 31, 2026.

Grant, award or other acquisition pursuant to Rule 16b-3(d)

• F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.
• F2 One-third of the RSUs shall vest on each of August 3, 2027, August 3, 2028 and August 3, 2029.

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

• F1 Represents shares withheld by Zimmer Biomet Holdings, Inc. (the Company) to satisfy tax withholding obligations on the vesting of restricted stock units (RSUs).

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

• F2 Each RSU represents a contingent right to receive one share of Company common stock.
• F3 One-third of the RSUs vested on August 1, 2026. The remaining RSUs vest one-half on each of August 1, 2027 and August 1, 2028.

Grant, award or other acquisition pursuant to Rule 16b-3(d)

• F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
• F3 Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

Grant, award or other acquisition pursuant to Rule 16b-3(d)

• F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
• F3 Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

Grant, award or other acquisition pursuant to Rule 16b-3(d)

• F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
• F3 Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

Grant, award or other acquisition pursuant to Rule 16b-3(d)

• F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
• F3 Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

Grant, award or other acquisition pursuant to Rule 16b-3(d)

• F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
• F3 Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

Grant, award or other acquisition pursuant to Rule 16b-3(d)

• F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
• F3 Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

Grant, award or other acquisition pursuant to Rule 16b-3(d)

• F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
• F3 Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

Grant, award or other acquisition pursuant to Rule 16b-3(d)

• F1 Each RSU represents a contingent right to receive one share of Company common stock.
• F2 Vests annually over three years in increments of one-third each year, commencing June 1, 2027.

Open market or private sale of non-derivative or derivative security

Open market or private sale of non-derivative or derivative security

Grant, award or other acquisition pursuant to Rule 16b-3(d)

• F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
• F3 Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
• F4 Includes 60.604 phantom stock units accrued on April 30, 2026, 57.375 phantom stock units accrued on January 30, 2026, 49.323 phantom stock units accrued on October 31, 2025 and 53.221 phantom stock units accrued on July 31, 2025, in each case under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Grant, award or other acquisition pursuant to Rule 16b-3(d)

• F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
• F5 The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.
• F6 Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Grant, award or other acquisition pursuant to Rule 16b-3(d)

• F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
• F3 Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director
• F4 Includes 21.697 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Grant, award or other acquisition pursuant to Rule 16b-3(d)

• F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
• F5 The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.
• F6 Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Grant, award or other acquisition pursuant to Rule 16b-3(d)

• F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
• F3 Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
• F4 Includes 7.812 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Grant, award or other acquisition pursuant to Rule 16b-3(d)

• F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
• F5 The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.
• F6 Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Grant, award or other acquisition pursuant to Rule 16b-3(d)

• F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
• F3 Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
• F4 Includes 106.777 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Grant, award or other acquisition pursuant to Rule 16b-3(d)

• F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
• F5 The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.
• F6 Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Grant, award or other acquisition pursuant to Rule 16b-3(d)

• F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
• F3 Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
• F4 Includes 34.300 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Grant, award or other acquisition pursuant to Rule 16b-3(d)

• F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
• F5 The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as of a Director or (2) the date that is three years after the grant date.
• F6 Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Grant, award or other acquisition pursuant to Rule 16b-3(d)

• F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
• F3 Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
• F4 Includes 5.662 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Grant, award or other acquisition pursuant to Rule 16b-3(d)

• F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
• F5 The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.
• F6 Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Grant, award or other acquisition pursuant to Rule 16b-3(d)

• F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
• F3 Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
• F4 Includes 93.883 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Grant, award or other acquisition pursuant to Rule 16b-3(d)

• F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
• F5 The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.
• F6 Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Grant, award or other acquisition pursuant to Rule 16b-3(d)

• F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
• F3 Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
• F4 Includes 16.937 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Grant, award or other acquisition pursuant to Rule 16b-3(d)

• F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
• F5 The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.
• F6 Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Grant, award or other acquisition pursuant to Rule 16b-3(d)

• F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
• F3 Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
• F4 Includes 53.557 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Grant, award or other acquisition pursuant to Rule 16b-3(d)

• F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
• F5 The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination as a Director or (2) the date that is three years after the grant date.
• F6 Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Grant, award or other acquisition pursuant to Rule 16b-3(d)

• F1 Each Restricted Stock Unit represents a contingent right to receive one share of the Company's common stock.
• F2 Vests annually over three years in increments of one-third each year, commencing on May 1, 2027.

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

• F1 Includes 202 shares acquired under the Employee Stock Purchase Plan on December 31, 2025.

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

• F2 Represents shares withheld by Zimmer Biomet Holdings, Inc. (the Company) to satisfy tax withholding on the vesting of restricted stock units (RSUs).